학술논문
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Grand'Maison, Francois; Jacques, Francois; Traboulsee, Anthony; Tyblova, Michaela; Meluzinova, Eva; Ampapa, Radek; Valis, Martin; Hradilke, Pavel; Mareš, Miroslav; Stourac, Pavel; Gross-Paju, Katrin; Laplaud, David; Mathey, Guillaume; Uitdehaag, Bernard; Evdoshenkoo, Evgeny; Popova, Ekaterina; Zakharova, Maria; Totolyan, Natalia; Litvinenko, Igor; Khabirov, Farit; Sivertseva, Stella; Hancinova, Viera; Kantorova, Ema; Gines, Maria Luisa Martinez; Montalban, Xavier; Maduano, Sara Eichau; Meca-Lallana, Jose; Ramió-Torrentà, Lluís; Nehrych, Tetyanna; Pashkovskyy, Valeriy; Moskovko, Sergii; Kalbus, Oleksandr; Khavunka, Marta; Pryshchepa, Volodymyr; Goloborodko, Alla; Wynn, Daniel; Honeycutt, William; Wray, Sibyl; Steingo, Brian; LaGanke, Christopher; Huang, Deren; Hemphill, John Michael; Goldstick, Lawrence; Robertson, Derrick; Reich, Daniel S ; Arnold, Douglas L; Vermersch, Patrick; Bar-Or, Amit; Fox, Robert J; Matta, Andre; Turner, Timothy; Wallström, Erik; Zhang, Xinyan; Khabirov, Farit A
Source
In The Lancet Neurology September 2021 20(9):729-738
Subject
Language
ISSN
1474-4422